Abstract
Flavonoids are secondary metabolites produced in plants that have diverse biological activities. The present review summarizes information gathered mostly in the last six years on the flavonoids structure-activity relationships, specifically with respect to: A) phytoestrogenic activity – flavonoids potential to replace estrogen during the menopausal period and especially fascinating, the possibility of finding flavonoids selective for estrogen receptor β; B) as antioxidants – their potential to treat oxidative stress-associated diseases; C) as whitening agents – potentially active via their ability to inhibit the enzyme tyrosinase; D) flavonoids that are active due to their interaction with proteins (enzymes, receptors, transporters and transcription factors), an area which we believe will attract much more attention in the near future, in helping to understand the role of flavonoids and their mechanism of action in the treatment of human diseases. This review covers data collected from experiments performed using flavonoids with known structure rather than crude extracts, and in the first two sections (A and B), the focus is on results obtained from in-vivo experiments, where available.
Keywords: Antioxidants, Flavonoids, Phytoestrogen, Protein interaction, Whitening agent, phytoestrogenic activity, hormone-replacement therapy (HRT), estrogen receptors (ER), agonism, ER -selective antagonists, QSAR Models, Docking Analysis, Superposition Analysis, SERM, thiobarbitoric reactive substances (TBARS)
Current Organic Chemistry
Title: Structure-Activity Relationships of Flavonoids
Volume: 15 Issue: 15
Author(s): Vaya Jacob, Tavori Hagai and Khatib Soliman
Affiliation:
Keywords: Antioxidants, Flavonoids, Phytoestrogen, Protein interaction, Whitening agent, phytoestrogenic activity, hormone-replacement therapy (HRT), estrogen receptors (ER), agonism, ER -selective antagonists, QSAR Models, Docking Analysis, Superposition Analysis, SERM, thiobarbitoric reactive substances (TBARS)
Abstract: Flavonoids are secondary metabolites produced in plants that have diverse biological activities. The present review summarizes information gathered mostly in the last six years on the flavonoids structure-activity relationships, specifically with respect to: A) phytoestrogenic activity – flavonoids potential to replace estrogen during the menopausal period and especially fascinating, the possibility of finding flavonoids selective for estrogen receptor β; B) as antioxidants – their potential to treat oxidative stress-associated diseases; C) as whitening agents – potentially active via their ability to inhibit the enzyme tyrosinase; D) flavonoids that are active due to their interaction with proteins (enzymes, receptors, transporters and transcription factors), an area which we believe will attract much more attention in the near future, in helping to understand the role of flavonoids and their mechanism of action in the treatment of human diseases. This review covers data collected from experiments performed using flavonoids with known structure rather than crude extracts, and in the first two sections (A and B), the focus is on results obtained from in-vivo experiments, where available.
Export Options
About this article
Cite this article as:
Jacob Vaya, Hagai Tavori and Soliman Khatib, Structure-Activity Relationships of Flavonoids, Current Organic Chemistry 2011; 15 (15) . https://dx.doi.org/10.2174/138527211796367309
DOI https://dx.doi.org/10.2174/138527211796367309 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti- Rheumatic Drugs (DMARDs)
Current Vascular Pharmacology The Effect of Local Alcohol Delivery in Reducing Intimal Hyperplasia Induced by Vascular Injury and the Clinical Implications
Vascular Disease Prevention (Discontinued) Advancement in Microsponge Drug Delivery System: Preparation Methods, Patents and Commercial Utility
Recent Patents on Drug Delivery & Formulation Design, Synthesis and Cytotoxicity of Chalcone Analogs Derived from 2-Phenylimino-3-phenylthiazolidin-4-one
Letters in Drug Design & Discovery Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials
Current Clinical Pharmacology Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design “Seeing is Believing”: Perspectives of Applying Imaging Technology in Discovery Toxicology
Combinatorial Chemistry & High Throughput Screening Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?
Combinatorial Chemistry & High Throughput Screening Global Cardiovascular Risk Management in Primary Prevention
Current Vascular Pharmacology Trends in the Design and Application of Optical Chemosensors in Pharmaceutical and Biomedical Analysis
Current Pharmaceutical Analysis Intimal Hyperplasia in Murine Models
Current Drug Targets Development of Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology to Facilitate Drug Discovery and Translational Medicine
Current Bioinformatics Editorial (A New Era for Medicinal Chemistry)
Mini-Reviews in Medicinal Chemistry A New Validated HPLC-DAD Method for Estimation of Solasodine from Solanum nigrum Linn. Extracts and Formulations
The Natural Products Journal Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets High Throughput Mutation Screening by Automated Capillary Electrophoresis
Combinatorial Chemistry & High Throughput Screening Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Intestinal Barrier Dysfunction in Human Pathology and Aging
Current Pharmaceutical Design Gastrophysics of the Oral Cavity
Current Pharmaceutical Design Is there any Additional Prognostic Value of Central Blood Pressure Wave Forms Beyond Peripheral Blood Pressure?
Current Pharmaceutical Design